Cargando…

Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson's Disease

BACKGROUND: Pharyngeal dysphagia is a common symptom of Parkinson's disease (PD) leading to severe complications. PD-related pharyngeal dysphagia (PDrPD) may significantly improve in up to half of patients following acute oral levodopa challenge. OBJECTIVE: The aim of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labeit, Bendix, Claus, Inga, Muhle, Paul, Suntrup-Krueger, Sonja, Dziewas, Rainer, Warnecke, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086436/ https://www.ncbi.nlm.nih.gov/pubmed/32257098 http://dx.doi.org/10.1155/2020/4260501

Ejemplares similares

Pharyngeal electrical stimulation for postextubation dysphagia in acute stroke: a randomized controlled pilot trial
por: Suntrup-Krueger, Sonja, et al.
Publicado: (2023)

Costs of post-stroke dysphagia during acute hospitalization from a health-insurance perspective
por: Labeit, Bendix, et al.
Publicado: (2022)

Relationship between post-stroke dysphagia and pharyngeal sensory impairment
por: Labeit, Bendix, et al.
Publicado: (2023)

Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?
por: Labeit, Bendix, et al.
Publicado: (2019)

Pharyngeal dysphagia due to Varicella zoster virus meningoradiculitis and full recovery: Case report and endoscopic findings
por: Muhle, Paul, et al.
Publicado: (2018)

Oropharyngeal Dysphagia and Impaired Motility of the Upper Gastrointestinal Tract—Is There a Clinical Link in Neurocritical Care?
por: Muhle, Paul, et al.
Publicado: (2021)

Substance P Saliva Reduction Predicts Pharyngeal Dysphagia in Parkinson's Disease
por: Schröder, Jens Burchard, et al.
Publicado: (2019)

The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis
por: Labeit, Bendix, et al.
Publicado: (2020)

Dysphagia for medication in Parkinson’s disease
por: Labeit, Bendix, et al.
Publicado: (2022)

Effects of cognitive and motor dual-tasks on oropharyngeal swallowing assessed with FEES in healthy individuals
por: Muhle, Paul, et al.
Publicado: (2020)

Inter-rater and test-retest reliability of the “standardized endoscopic swallowing evaluation for tracheostomy decannulation in critically ill neurologic patients”
por: Warnecke, Tobias, et al.
Publicado: (2020)

Sarcopenic Dysphagia Revisited: A Cross-Sectional Study in Hospitalized Geriatric Patients
por: Calles, Marcel, et al.
Publicado: (2023)

Targeting the sensory feedback within the swallowing network—Reversing artificially induced pharyngolaryngeal hypesthesia by central and peripheral stimulation strategies
por: Muhle, Paul, et al.
Publicado: (2020)

Dysphagia in Patients With Severe Coronavirus Disease 2019—Potential Neurologic Etiologies
por: Dziewas, Rainer, et al.
Publicado: (2021)

Pharyngolaryngeal Sensory Deficits in Patients with Middle Cerebral Artery Infarction: Lateralization and Relation to Overall Dysphagia Severity
por: Marian, Thomas, et al.
Publicado: (2017)

Standardized Endoscopic Swallowing Evaluation for Tracheostomy Decannulation in Critically Ill Neurologic Patients – a prospective evaluation
por: Muhle, Paul, et al.
Publicado: (2021)

Effect of Capsaicinoids on Neurophysiological, Biochemical, and Mechanical Parameters of Swallowing Function
por: Suntrup-Krueger, Sonja, et al.
Publicado: (2021)

Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test
por: Warnecke, Tobias, et al.
Publicado: (2021)

Altered Cortical Swallowing Processing in Patients with Functional Dysphagia: A Preliminary Study
por: Suntrup, Sonja, et al.
Publicado: (2014)

Clinical determinants and neural correlates of presbyphagia in community-dwelling older adults
por: Labeit, Bendix, et al.
Publicado: (2022)

Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020)

Bilateral vocal cord palsy as complication of CNS tuberculosis
por: Regner-Nelke, Liesa, et al.
Publicado: (2023)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
por: Othman, Ahmed A, et al.
Publicado: (2014)

Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
por: Othman, Ahmed A., et al.
Publicado: (2015)

Measurement of Oxygen Desaturation Is Not Useful for the Detection of Aspiration in Dysphagic Stroke Patients
por: Marian, Thomas, et al.
Publicado: (2017)

Long‐term safety and effectiveness of levodopa‐carbidopa intestinal gel infusion
por: De Fabregues, Oriol, et al.
Publicado: (2017)

Cortical Processing of Swallowing in ALS Patients with Progressive Dysphagia – A Magnetoencephalographic Study
por: Teismann, Inga K., et al.
Publicado: (2011)

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
por: Müller, Thomas, et al.
Publicado: (2022)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance
por: Nyholm, Dag, et al.
Publicado: (2022)

Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson’s Disease Treatment
por: Nomoto, Yusuke, et al.
Publicado: (2023)

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy
por: Loens, Sebastian, et al.
Publicado: (2017)

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐release carbidopa‐levodopa (Sinemet(®) CR), and carbidopa‐levodopa‐entacapone (Stalevo(®))
por: Hsu, Ann, et al.
Publicado: (2015)

Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson’s Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2017)

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
por: Torres, Viviana, et al.
Publicado: (2022)

Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review
por: Ueno, Tatsuya, et al.
Publicado: (2021)

Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Improvement of Primary Writing Tremor in Parkinson’s Disease with Carbidopa/Levodopa
por: Battista, James P., et al.
Publicado: (2015)

Extended-release oral capsule of carbidopa–levodopa in Parkinson disease
por: Margolesky, Jason, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g1ru8rocgjqmbmehfav0nqnfoc